Skip to main content

Novel Rx

      A study presents a novel urinary biomarker panel that predicts histologically active lupus nephritis (LN) with high accu
      A study presents a novel urinary biomarker panel that predicts histologically active lupus nephritis (LN) with high accuracy. Key findings: - AUC of 90% for predicting NIH Activity Index > 2, outperforming traditional biomarkers. - Identified 12 critical proteins linked to… https://t.co/6ZhqNaxpQM
      When the ACR Convergence 2024 abstract site went live, the first query I typed into the search bar was, “CAR-T.” I consider myself a CAR-T skeptic and would be surprised if the magical results…
      Day 1 Recap at ACR24
      This year at #ACR24, emulation trials are being presented.Are these ‘trials’ helpful, despite the biases that occur with observational data, or do they truly mimic the results of randomized…
      Phase 2 DBRCT of daxdilimab, an immunoglobulin-like transcript 7 to target plasmacytoid dendritic cells

      No difference i
      1 month ago
      Phase 2 DBRCT of daxdilimab, an immunoglobulin-like transcript 7 to target plasmacytoid dendritic cells No difference in primary outcome... but kiiiinda looks like something there? I dislike Phase 2's; should go straight to Phase 3 if able #ACR24 @rheumnow Abstr#1542 https://t.co/osDWDskfnA
      Too Many CAR-Ts?
      ×